I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
ABONOUR, RAFAT
170
results:
Search for persons
X
Format
Online (170)
Mediatypes
Articles (Online) (101)
Bookchapter (Online) (2)
OpenAccess-fulltext (67)
Sorted by: Relevance
Sorted by: Year
?
1
The effect of age and other patient characteristics on outc..:
Abonour, Rafat
;
Lee, Hans C.
;
Rifkin, Robert
...
Clinical Lymphoma Myeloma and Leukemia. , 2024
Link:
https://doi.org/10.1016/..
?
2
Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (..:
Patel, Krina K.
;
Rodríguez-Otero, Paula
;
Nooka, Ajay K.
...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S322 , 2024
Link:
https://doi.org/10.1016/..
?
3
Impact of prior lenalidomide or proteasome inhibitor exposu..:
Lee, Hans C.
;
Ramasamy, Karthik
;
Macro, Margaret
...
European Journal of Haematology. 113 (2024) 2 - p. 190-200 , 2024
Link:
https://doi.org/10.1111/..
?
4
High‐dose chemotherapy and peripheral blood stem cell trans..:
Richardson, Noah H.
;
Taza, Fadi
;
Abonour, Rafat
...
Cancer. , 2024
Link:
https://doi.org/10.1002/..
?
5
1q amplification and PHF19 expressing high-risk cells are a..:
Johnson, Travis S.
;
Sudha, Parvathi
;
Liu, Enze
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
6
OA-32 The impact of genomics to identify novel immunotherap..:
Liu, Enze
;
Sudha, Parvathi
;
Zaid, Mohammad Abu
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S19-S20 , 2023
Link:
https://doi.org/10.1016/..
?
7
OA-27 Single cell transcriptomics reveals the impact of tum..:
Sudha, Parvathi
;
Zaid, Mohammad Abu
;
Johnson, Travis
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S16-S17 , 2023
Link:
https://doi.org/10.1016/..
?
8
Rates of Influenza and Pneumococcal Vaccination and Correla..:
Thompson, Michael A.
;
Boccadoro, Mario
;
Leleu, Xavier
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 3 - p. e171-e181 , 2023
Link:
https://doi.org/10.1016/..
?
9
P-008 Idecabtagene vicleucel (ide-cel) vs standard regimens..:
Einsele, Hermann
;
Rodriguez-Otero, Paula
;
Arnulf, Bertrand
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S37 , 2023
Link:
https://doi.org/10.1016/..
?
10
Using a Modified Delphi Panel to Estimate Health Service Ut..:
Gertz, Morie
;
Abonour, Rafat
;
Gibbs, Sarah
...
ClinicoEconomics and Outcomes Research. 15 (2023) - p. 673-680 , 2023
Link:
https://doi.org/10.2147/..
?
11
P-285 Real-world clinical outcomes and treatment patterns a..:
Lee, Hans
;
Ailawadhi, Sikander
;
Dhanda, Devender
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S193-S194 , 2023
Link:
https://doi.org/10.1016/..
?
12
Identifying novel mechanisms of biallelic TP53 loss refines..:
Liu, Enze
;
Sudha, Parvathi
;
Becker, Nathan
...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
13
Treatment Patterns, Survival, Quality of Life, and Healthca..:
Lee, Hans C.
;
Ramasamy, Karthik
;
Weisel, Katja
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 2 - p. 112-122 , 2023
Link:
https://doi.org/10.1016/..
?
14
In-Class Transition from Bortezomib-Based Therapy to IRd is..:
Rifkin, Robert M
;
Costello, Caitlin L
;
Birhiray, Ruemu E
...
Future Oncology. 20 (2023) 3 - p. 131-143 , 2023
Link:
https://doi.org/10.2217/..
?
15
P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS ..:
Abonour, Rafat
;
Rifkin, Robert
;
Ailawadhi, Sikander
...
HemaSphere. 7 (2023) S3 - p. e52503e2 , 2023
Link:
https://doi.org/10.1097/..
1-15